<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology was formed to acquire a portfolio of various medical lice...

    Global Cancer Technology was formed to acquire ...

    Fundraising Status:    EC
    Filing Type:    RA
    Immutep Limited

    Immutep Limited

    We are a biotechnology company developing novel immunotherapy treatments for cance...

    We are a biotechnology company developing novel...

    Filing Type:    PU
    Viking Therapeutics, Inc.

    Viking Therapeutics, Inc.

    Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the d...

    Viking Therapeutics is a clinical-stage biophar...

    Filing Type:    PU
    Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology compan...

    Axonics Modulation Technologies, Inc. (NASDAQ:A...

    Filing Type:    PU
    SiNtx Technologies, Inc.

    SiNtx Technologies, Inc.

    SINTX Technologies is a commercial biomaterial company focused on using its silico...

    SINTX Technologies is a commercial biomaterial ...

    Filing Type:    PU
    Coherus BioSciences, Inc.

    Coherus BioSciences, Inc.

    Coherus BioSciences is a leading biosimilar company that develops and commercializ...

    Coherus BioSciences is a leading biosimilar com...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    ImmunoGen, Inc.

    ImmunoGen, Inc.

    ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to ...

    ImmunoGen is developing the next generation of ...

    Filing Type:    PU
    Anchiano Therapeutics Ltd.

    Anchiano Therapeutics Ltd.

    We are Anchiano Therapeutics, a pivotal-stage biopharmaceutical company focused on...

    We are Anchiano Therapeutics, a pivotal-stage b...

    Filing Type:    PU
    Ascendis Pharma A/S

    Ascendis Pharma A/S

    Ascendis Pharma is applying its innovative technology platform to build a leading,...

    Ascendis Pharma is applying its innovative tech...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.